Ipsen obtains an exclusive license to develop, manufacture and commercialize a pre-clinical stage METTL3-inhibitor programme
These aprons utilise phase change materials that absorb, store and release heat for optimal thermal comfort
Revlimid is a blood cancer drug with sales of US $ 12.1 billion in 2020
Trillium’s portfolio includes biologics that are designed to enhance the ability of patients’ innate immune system to detect and destroy cancer cells
Lenalidomide is used to treat cancer and also some anaemia disorders
_256_384.jpg)
It has initiated investments for advanced medical equipment such as Cath Labs, neuro microscopes, bone marrow transplant units at select facilities
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
